177 related articles for article (PubMed ID: 32181728)
1. Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up.
Vernuccio F; Ronot M; Dioguardi Burgio M; Cauchy F; Choudhury KR; Dokmak S; Soubrane O; Valla D; Zucman-Rossi J; Paradis V; Vilgrain V
Radiology; 2020 May; 295(2):361-372. PubMed ID: 32181728
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification.
Laumonier H; Bioulac-Sage P; Laurent C; Zucman-Rossi J; Balabaud C; Trillaud H
Hepatology; 2008 Sep; 48(3):808-18. PubMed ID: 18688875
[TBL] [Abstract][Full Text] [Related]
3. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification.
van Aalten SM; Thomeer MG; Terkivatan T; Dwarkasing RS; Verheij J; de Man RA; Ijzermans JN
Radiology; 2011 Oct; 261(1):172-81. PubMed ID: 21875850
[TBL] [Abstract][Full Text] [Related]
6. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
[TBL] [Abstract][Full Text] [Related]
7. Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience.
Grieser C; Steffen IG; Kramme IB; Bläker H; Kilic E; Perez Fernandez CM; Seehofer D; Schott E; Hamm B; Denecke T
Eur Radiol; 2014 Jun; 24(6):1339-48. PubMed ID: 24658870
[TBL] [Abstract][Full Text] [Related]
8. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI.
Denecke T; Steffen IG; Agarwal S; Seehofer D; Kröncke T; Hänninen EL; Kramme IB; Neuhaus P; Saini S; Hamm B; Grieser C
Eur Radiol; 2012 Aug; 22(8):1769-75. PubMed ID: 22437921
[TBL] [Abstract][Full Text] [Related]
9. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
[TBL] [Abstract][Full Text] [Related]
10. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
[TBL] [Abstract][Full Text] [Related]
11. Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A.
Resaz R; Rosa F; Grillo F; Basso L; Segalerba D; Puglisi A; Bosco MC; Mastracci L; Neumaier CE; Varesio L; Eva A
Dis Model Mech; 2019 Apr; 12(4):. PubMed ID: 30898969
[TBL] [Abstract][Full Text] [Related]
12. Pigmented hepatocellular adenoma with β-catenin activation: case report and literature review.
Coelho R; Gonçalves R; Carneiro F; Fernandes M; Lopes J; Guimarães S; Macedo G
Ann Hepatol; 2016; 15(4):598-603. PubMed ID: 27236161
[TBL] [Abstract][Full Text] [Related]
13. Should fat in the radiofrequency ablation zone of hepatocellular adenomas raise suspicion for residual tumour?
Costa AF; Kajal D; Pereira A; Atri M
Eur Radiol; 2017 Apr; 27(4):1704-1712. PubMed ID: 27436025
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
[TBL] [Abstract][Full Text] [Related]
15. Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas.
Tse JR; Naini BV; Lu DS; Raman SS
Radiology; 2016 Apr; 279(1):118-27. PubMed ID: 26505921
[TBL] [Abstract][Full Text] [Related]
16. MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents.
Thomeer MG; Willemssen FE; Biermann KK; El Addouli H; de Man RA; Ijzermans JN; Dwarkasing RS
J Magn Reson Imaging; 2014 May; 39(5):1259-64. PubMed ID: 23897798
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of hepatocellular adenomas on genotype-phenotype classification: A report from China.
Wang H; Yang C; Rao S; Ji Y; Han J; Sheng R; Zeng M
Eur J Radiol; 2018 Mar; 100():135-141. PubMed ID: 29496071
[TBL] [Abstract][Full Text] [Related]
18. A nationwide assessment of hepatocellular adenoma resection: Indications and pathological discordance.
Haring MPD; Elfrink AKE; Oudmaijer CAJ; Andel PCM; Furumaya A; de Jong N; Willems CJJM; Huits T; Sijmons JML; Belt EJT; Bosscha K; Consten ECJ; Coolsen MME; van Duijvendijk P; Erdmann JI; Gobardhan P; de Haas RJ; van Heek T; Lam HD; Leclercq WKG; Liem MSL; Marsman HA; Patijn GA; Terkivatan T; Zonderhuis BM; Molenaar IQ; Te Riele WW; Hagendoorn J; Schaapherder AFM; IJzermans JNM; Buis CI; Klaase JM; de Jong KP; de Meijer VE;
Hepatol Commun; 2023 Jan; 7(1):e2110. PubMed ID: 36324268
[TBL] [Abstract][Full Text] [Related]
19. PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions.
Lee SY; Kingham TP; LaGratta MD; Jessurun J; Cherqui D; Jarnagin WR; Kluger MD
HPB (Oxford); 2016 Jan; 18(1):41-8. PubMed ID: 26776850
[TBL] [Abstract][Full Text] [Related]
20. The effect of oral contraceptive pill cessation on hepatocellular adenoma diameter: A retrospective cohort study.
Haring MPD; Gouw ASH; de Haas RJ; Cuperus FJC; de Jong KP; de Meijer VE
Liver Int; 2019 May; 39(5):905-913. PubMed ID: 30773766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
